ASX Announcements
Market Sensitive
S&P DJI Announces March 2024 Quarterly Rebalance
Standard and Poor’s Announcement
- Mar 1, 2024
- 8 pages
Notification of cessation of securities - PME
Appendix 3H (Notification of cessation of securities)
- Feb 27, 2024
- 4 pages
April
- Opinion
- Chanticleer
12 stock picks for a tough investing environment
Low rates and endless stimulus may have left investors unprepared for the difficult environment that lies ahead. Here are 12 stock picks to consider.
- James Thomson
Why Paradice is backing Seven Group’s bid for Boral
Mid-cap investor Jovana Gagic says Kerry Stokes’ conglomerate has a good track record in buying controlling stakes, and reveals why she’s bullish on Orica and Pro Medicus.
- Joanne Tran
February
Pro Medicus share price pause ‘a good entry point’
A $2.8 million share buyback has helped restore $1.2 billion of value to Pro Medicus. Despite its sky-high multiple, bulls think it has further to run.
- Tess Bennett
Why analysts love these eight medtech stocks
The sector that straddles healthcare and tech has professionals searching for companies that could be tomorrow’s big winners after Pro Medicus.
- Tom Richardson
The Aussies hoping to make a fortune from Apple’s Vision Pro
The $11 billion ASX software giant Pro Medicus and a Melbourne start-up are among the businesses hoping to cash in on Apple’s new $5000 headset.
- Tess Bennett
January
Newmont to slide down ASX 200 as investors ditch secondary listings
The gold giant’s addition to the Australian Stock Exchange is expected to see a major reshuffle of the indices and $746 million worth of trading at the quarterly rebalance.
- Alex Gluyas
December 2023
The Australian Financial Review names its Business Person of the Year
Gina Rinehart has capped an extraordinary year of deal-making across the mining, energy, agribusiness and retail sectors by taking out the top honour.
- James Thomson
How Sam Hupert turned Pro Medicus into an understated giant
With a team of just 115 people and an understated approach to business, the healthtech co-founder has created an Australian success story.
- James Thomson
Why First Sentier ‘really likes’ Pro Medicus
Portfolio manager Alison Thai is backing the technology company despite its high valuation and explains why she is sticking with Megaport, even after a recent negative surprise.
- Joanne Tran
November 2023
Nine small-cap stocks tipped to soar in 2024
If central banks cut interest rates next year as widely predicted, then small-cap stocks could surge as risk appetite returns, investors say.
- Tom Richardson
Pro Medicus founders in $176m selldown; Unified Capital nabs trade
Fund manager sources said Anthony Hall and Sam Hupert had stockbroker Unified Capital Partners seeking buyers for 2 million shares at $88 apiece.
- Sarah Thompson, Kanika Sood and Emma Rapaport
October 2023
This hedge fund shorted Qantas as Joyce was selling
Marcus Hughes followed Alan Joyce’s lead. He shorted the stock, betting the value of Qantas shares would fall. “Whenever an insider sells, we’ll look at shorting a company.” It worked.
- Joanne Tran
This Rich Lister added $1b to his wealth in less than two years
Medical technology firm Pro Medicus has delivered blistering returns this year. Its success has propelled co-founder Sam Hupert into the $2 billion club.
- Julie-anne Sprague
August 2023
- Opinion
- Chanticleer
What we learnt from Temple & Webster, Cochlear and Pro Medicus’ results
Chanticleer columnists James Thomson and Anthony Macdonald take a deep dive into Tuesday’s key profit results.
- James Thomson and Anthony Macdonald
July 2023
Why the boss of this $7b company is wary about the hype around ChatGPT
Pro Medicus CEO Sam Hupert also says the company has benefited from an early decision to remain debt-free.
- Sally Patten and Patrick Durkin
The 10 wealthiest executives in the ASX 300 revealed
The Australian Financial Review’s Rich Bosses list for 2023 is dominated by mining and technology executives, and includes a displacement at the top spot.
- Euan Black
February 2023
Tech’s hottest stock Pro Medicus delivers jump in profit
The medical software imaging company has again delivered a record-breaking half, with revenue surging more than 28 per cent and net profit up 31.5 per cent to $27.2 million.
- Yolanda Redrup
January 2023
This quiet achiever shows why it was the hottest tech stock of 2022
Pro Medicus is continuing its stellar run, scoring its second big contract win in the last month on the back of a bumper 2022.
- Yolanda Redrup
November 2022
These 10 shares would have made you 888pc-plus in a decade
A standout lesson from the top performers over the last 10 years is that investors who ignore Australian IT companies do so at their peril.
- Jennifer Mead
October 2022
Buy, hold, sell: Five resilient cash cows
Two fundies give their analysis of three profitable ASX darlings and share one small cap that they believe will continue to spew out cash (and remain resilient) over the year ahead.